13D/13G Filings - Maze Therapeutics Inc. (MAZE)

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2025-02-10
10:55 am
Purchase
2025-02-0313GMaze Therapeutics Inc.
MAZE
Frazier Life Sciences Public Fund, L.P. 3,193,900
7.300%
3,193,900increase
(New Position)
Filing
History
2025-02-07
4:30 pm
Purchase
2025-01-3113GMaze Therapeutics Inc.
MAZE
Deep Track Capital, LP3,023,484
6.910%
3,023,484increase
(New Position)
Filing
History
2025-02-07
4:01 pm
Unchanged
2025-01-3113GMaze Therapeutics Inc.
MAZE
Foresite Capital Fund IV, L.P.2,457,108
5.600%
0
(Unchanged)
Filing
History
2025-02-07
4:01 pm
Purchase
2025-01-3113GMaze Therapeutics Inc.
MAZE
Foresite Capital Fund IV, L.P.2,457,108
5.600%
2,457,108increase
(New Position)
Filing
History